Dr. Robert Orlowski says a single-drug option in newly diagnosed myeloma may offer strong responses with fewer side effects and preserve future treatments.
Dr. Robert Orlowski
Advertisement
Articles by Dr. Robert Orlowski
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
A New Option Without Traditional Chemotherapy for Ph+ ALL
2
Azacitidine Plus Venclexta Superior to Chemo in Acute AML
3
Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit
4
Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma
5
